Position in ABBV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$4,642,505
+$578,488 QoQ
Shares Held
18,449
-1.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.93%
of 13F equity value
Holder Rank
#1,358
of 4,153 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Alpine Bank Wealth Management holds $12,153,060 across 11 Drug Manufacturers - General names. ABBV ranks #1 (38.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
18,449 | $4,642,505 | |
| 2 | JNJ |
Johnson & Johnson
|
8,036 | $2,040,902 | |
| 3 | LLY |
ELI LILLY & Co
|
1,388 | $1,664,808 | |
| 4 | MRK |
Merck & Co., Inc.
|
12,893 | $1,656,750 | |
| 5 | PFE |
Pfizer Inc
|
32,082 | $772,533 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
9,893 | $570,034 | |
| 7 | AMGN |
Amgen Inc
|
1,156 | $418,610 | |
| 8 | NVO |
Novo Nordisk A S
|
3,000 | $143,820 |
All Filings in ABBV
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,642,505 | 18,449 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $4,064,017 | 18,686 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $4,148,463 | 18,156 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $4,209,396 | 18,180 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $3,371,972 | 18,166 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $3,878,843 | 18,513 | Shares | Sole | 2025-04-23 | |
| No filing history on record for this holder in this stock. | ||||||